Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)
October 06 2015 - 5:31PM
Edgar (US Regulatory)
|
|
|
|
|
October 2015
Pricing Sheet dated October 5, 2015 relating
to Preliminary Terms No. 481 dated September 24, 2015
Registration Statement No. 333-199966
Filed pursuant to Rule 433 |
STRUCTURED INVESTMENTS
Opportunities in U.S. Equities
PLUS Based on the Value of the S&P
500® Index due October 13, 2016
Performance Leveraged Upside
SecuritiesSM
Principal at Risk Securities
|
|
|
|
|
|
|
PRICING TERMS October 2, 2015 |
|
|
Issuer: |
|
JPMorgan Chase & Co. |
Underlying index: |
|
S&P 500® Index |
Aggregate principal amount: |
|
$4,220,600 |
Payment at maturity: |
|
If the final index value is greater than the initial index value, for each $10 stated principal amount PLUS,
$10 + leveraged upside payment
In no event will the payment at maturity exceed the maximum payment at maturity.
If the final index value is less than or equal to the initial index value, for each $10 stated principal amount PLUS,
$10 × index performance factor
This amount will be less than or equal to the stated principal amount of $10 per PLUS. |
Leveraged upside payment: |
|
$10 × leverage factor × index percent increase |
Index percent increase: |
|
(final index value initial index value) / initial index value |
Initial index value: |
|
The closing level of the underlying index on the pricing date, which was 1,951.36 |
Final index value: |
|
The closing level of the underlying index on the valuation date |
Leverage factor: |
|
300% |
Index performance factor: |
|
final index value / initial index value |
Maximum payment at maturity: |
|
$11.30 (113.00% of the stated principal amount) per PLUS. |
Stated principal amount: |
|
$10 per PLUS |
Issue price: |
|
$10 per PLUS (see Commissions and issue price below) |
Pricing date: |
|
October 2, 2015 |
Original issue date (settlement date): |
|
October 7, 2015 |
Valuation date: |
|
October 10, 2016, subject to postponement in the event of certain market disruption events and as described under General Terms of Notes Postponement of a Determination Date in the accompanying product
supplement no. 4a-I |
Maturity date: |
|
October 13, 2016, subject to postponement in the event of certain market disruption events and as described under General Terms of Notes Postponement of a Payment Date in the accompanying product
supplement no. 4a-I |
CUSIP / ISIN: |
|
48127Y722 / US48127Y7224 |
Listing: |
|
The PLUS will not be listed on any securities exchange. |
Agent: |
|
J.P. Morgan Securities LLC (JPMS) |
|
|
|
|
|
|
|
Commissions and issue price: |
|
Price to public(1) |
|
Fees and commissions |
|
Proceeds to issuer |
Per PLUS |
|
$10 |
|
$0.175(2) |
|
$9.775 |
|
|
|
|
$0.05(3) |
|
|
Total |
|
$4,220,600.00 |
|
$94,963.50 |
|
$4,125,636.50 |
|
(1) |
See Additional Information about the PLUS Supplemental use of proceeds and hedging in the accompanying preliminary terms for information about the components of the price to public of the PLUS.
|
|
|
(2) |
JPMS, acting as agent for JPMorgan Chase & Co., will pay all of the selling commissions of $0.175 per $10 stated principal amount PLUS it receives from us to Morgan Stanley Smith Barney LLC (Morgan Stanley
Wealth Management). See Plan of Distribution (Conflicts of Interest) beginning on page PS-87 of the accompanying product supplement no. 4a-I. |
|
|
(3) |
Reflects a structuring fee payable to Morgan Stanley Wealth Management by the agent or its affiliates of $0.05 for each PLUS |
|
The estimated value of the PLUS on the pricing date as determined by JPMS was $9.733 per $10 stated principal amount PLUS.
See Additional Information about the PLUS JPMSs estimated value of the PLUS in the accompanying preliminary terms for additional information.
The PLUS are not bank deposits, are not insured by the Federal Deposit Insurance Corporation or any other governmental agency and are not obligations of, or guaranteed
by, a bank.
You should read this document together with the preliminary terms describing the offering and the related product supplement no. 4a-I,
underlying supplement no. 1a-I, prospectus supplement and prospectus, each of which can be accessed via the hyperlinks below. Please also see Additional Information about the PLUS in the accompanying preliminary terms.
Preliminary terms no. 481 dated September
24, 2015: http://www.sec.gov/Archives/edgar/data/19617/000114036115035908/formfwp.htm
Product supplement no. 4a-I dated November
7, 2014: http://www.sec.gov/Archives/edgar/data/19617/000089109214008407/e61359_424b2.pdf
Underlying supplement no. 1a-I dated November
7, 2014: http://www.sec.gov/Archives/edgar/data/19617/000089109214008410/e61337_424b2.pdf
Prospectus supplement and prospectus, each dated November 7, 2014:
http://www.sec.gov/Archives/edgar/data/19617/000089109214008397/e61348_424b2.pdf
The issuer has filed a registration statement (including a prospectus) with the Securities and Exchange Commission (the SEC) for the offering to
which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get
these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in this offering will arrange to send you the prospectus if you request it by calling toll-free
(800) 869-3326
JP Morgan Chase (NYSE:JPM)
Historical Stock Chart
From Aug 2024 to Sep 2024
JP Morgan Chase (NYSE:JPM)
Historical Stock Chart
From Sep 2023 to Sep 2024